Increased immune response variability during simultaneous viral coinfection leads to unpredictability in CD8 T cell immunity and pathogenesis

Journal of Virology

Volumn 89, Issue 21, 2015, Pages 10786-10801

  Kenney, Laurie ^a   Cornberg, Markus ^a,b   Chen, Alex ^a   Emonet, Sebastien ^c   de la Torre, Juan Carlos ^c   Selin, Liisa K ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; NUCLEOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LYMPHOCYTE COUNT; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MEMORY T LYMPHOCYTE; MIXED INFECTION; MOUSE; NONHUMAN; PICHINDE VIRUS; PRIORITY JOURNAL; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS PATHOGENESIS; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; PATHOPHYSIOLOGY; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; VIROLOGY;

ANALYSIS OF VARIANCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; COINFECTION; HUMANS; IMMUNOLOGIC MEMORY; MALE; MICE; MICE, INBRED C57BL; SEQUENCE HOMOLOGY; SPECIES SPECIFICITY;

EID: 84945208013     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01432-15     Document Type: Article

References (70)

1. Lam KS, Marshall ID. 1968. Dual infections of Aedes aegypti with arboviruses. I. Arboviruses that have no apparent cytopathic effect in the mosquito. Am J Trop Med Hyg 17:625-636.
2. Chamberlain RW, Sudia WD. 1957. Dual infections of eastern and western equine encephalitis viruses in Culex tarsalis. J Infect Dis 101:233-236. http://dx.doi.org/10.1093/infdis/101.3.233.
3. Bharaj P, Chahar HS, Pandey A, Diddi K, Dar L, Guleria R, Kabra SK, Broor S. 2008. Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi, India. Virol J 5:1. http://dx .doi.org/10.1186/1743-422X-5-1.
4. Esper FP, Spahlinger T, Zhou L. 2011. Rate and influence of respiratory virus co-infection on pandemic (H1N1) influenza disease. J Infect 63: 260-266. http://dx.doi.org/10.1016/j.jinf.2011.04.004.
5. Palacios G, Hornig M, Cisterna D, Savji N, Bussetti AV, Kapoor V, Hui J, Tokarz R, Briese T, Baumeister E, Lipkin WI. 2009. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One 4:e8540. http://dx.doi.org/10.1371/journal.pone .0008540.
6. Maier I,WuGY. 2002. Hepatitis C and HIV co-infection: a review. World J Gastroenterol 8:577-579.
7. Singal A-K, Anand BS. 2009. Management of hepatitis C virus infection in HIV/HCV co-infected patients: clinical review. World J Gastroenterol 15:3713-3724. http://dx.doi.org/10.3748/wjg.15.3713.
8. Grabowski J, Wedemeyer H. 2010. Hepatitis delta: immunopathogenesis and clinical challenges. Dig Dis 28:133-138. http://dx.doi.org/10.1159 /000282076.
9. Meyerhoff A, Jacobs RJ, Greenberg DP, Yagoda B, Castles CG. 2003. Clinician satisfaction with vaccination visits and the role of multiple injections, results from the COVISE Study (Combination Vaccines Impact on Satisfaction and Epidemiology). Clin Pediatr 43:87-93.
10. Woodin KA, Rodewald LE, Humiston SG, Carges MS, Schaffer SJ, Szilagyi PG. 1995. Physician and parent opinions. Are children becoming pincushions from immunizations? Arch Pediatr Adolesc Med 149:845-849.
11. Kroger AT, Sumaya CV, Pickering LK, Atkinson WL. 2011. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend Rep 60(RR-2):1-60.
12. Vidor E. 2007. The nature and consequences of intra-and inter-vaccine interference. J Comp Pathol 137(Suppl 1):S62-S66. http://dx.doi.org/10 .1016/j.jcpa.2007.04.014.
13. Ruben FL, Smith EA, Foster SO, Casey HL, Pifer JM, Wallace RB, Atta AI, Jones WL, Arnold RB, Teller BE, Shaikh ZQ, Lourie B, Eddins DL, Doko SM, Foege WH. 1973. Simultaneous administration of smallpox, measles, yellow fever, and diphtheria-pertussis-tetanus antigens to Nigerian children. Bull World Health Organ 48:175-181.
14. Brehm MA, Pinto AK, Daniels KA, Schneck JP, Welsh RM, Selin LK. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat Immunol 3:627-634.
15. Selin LK, Varga SM, Wong IC, Welsh RM. 1998. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J Exp Med 188:1705-1715. http://dx.doi.org /10.1084/jem.188.9.1705.
16. Chen AT, Cornberg M, Gras S, Guillonneau C, Rossjohn J, Trees A, Emonet S, la Torre de JC, Welsh RM, Selin LK. 2012. Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope. PLoS Pathog 8:e1002633. http://dx.doi.org/10.1371/journal.ppat .1002633.
17. Cornberg M, Chen AT, Wilkinson LA, Brehm MA, Kim S-K, Calcagno C, Ghersi D, Puzone R, Celada F, Welsh RM, Selin LK. 2006. Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity. J Clin Invest 116:1443-1456. http://dx.doi.org/10.1172/JCI27804.
18. Cornberg M, Clute SC, Watkin LB, Saccoccio FM, Kim S-K, Naumov YN, Brehm MA, Aslan N, Welsh RM, Selin LK. 2010. CD8 T cell cross-reactivity networks mediate heterologous immunity in human EBV and murine vaccinia virus infections. J Immunol 184:2825-2838. http: //dx.doi.org/10.4049/jimmunol.0902168.
19. + T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol 2:1067-1076. http://dx.doi.org/10 .1038/ni727.
20. Welsh RM, McNally JM, Brehm MA, Selin LK. 2000. Consequences of cross-reactive and bystander CTL responses during viral infections. Virology 270:4-8. http://dx.doi.org/10.1006/viro.2000.0278.
21. Nie S, Lin S-J, Kim S-K, Welsh RM, Selin LK. 2010. Pathological features of heterologous immunity are regulated by the private specificities of the immune repertoire. Am J Pathol 176:2107-2112. http://dx.doi.org/10 .2353/ajpath.2010.090656.
22. Kim S-K, Cornberg M, Wang XZ, Chen HD, Selin LK, Welsh RM. 2005. Private specificities of CD8 T cell responses control patterns of heterologous immunity. J Exp Med 201:523-533. http://dx.doi.org/10.1084/jem .20041337.
23. Nie S, Cornberg M, Selin LK. 2009. Resistance to vaccinia virus is less dependent on TNF under conditions of heterologous immunity. J Immunol 183:6554-6560. http://dx.doi.org/10.4049/jimmunol.0902156.
24. Cibotti R, Cabaniols JP, Pannetier C, Delarbre C, Vergnon I, Kanellopoulos JM, Kourilsky P. 1994. Public and private VT cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J Exp Med 180:861-872. http://dx.doi.org/10.1084 /jem.180.3.861.
25. Welsh RM, Lampert PW, Burner PA, Oldstone MB. 1976. Antibodycomplement interactions with purified lymphocytic choriomeningitis virus. Virology 73:59-71. http://dx.doi.org/10.1016/0042-6822(76)90060-X.
26. Welsh RM. 1978. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J Exp Med 148:163-181.
27. Selin LK, Nahill SR, Welsh RM. 1994. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J Exp Med 179:1933-1943. http://dx.doi.org/10.1084/jem.179.6.1933.
28. Cooper PD. 1959. Tetrazolium salts as stains for animal virus plaque assays. Virology 7:469-470. http://dx.doi.org/10.1016/0042-6822(59)90077-7.
29. Logan JC, Fox MP, Morgan JH, Makohon AM, Pfau CJ. 1975. Arenavirus inactivation on contact with N-substituted isatin betathiosemicarbazones and certain cations. J Gen Virol 28:271-283. http: //dx.doi.org/10.1099/0022-1317-28-3-271.
30. Walker CM, Rawls WE, Rosenthal KL. 1984. Generation of memory cell-mediated immune responses after secondary infection of mice with pichinde virus. J Immunol 132:469-474.
31. Cerny A, Sutter S, Bazin H, Hengartner H, Zinkernagel RM. 1988. Clearance of lymphocytic choriomeningitis virus in antibody-and B-celldeprived mice. J Virol 62:1803-1807.
32. Ahmed R, Salmi A, Butler LD, Chiller JM, Oldstone MB. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med 160:521-540.
33. Cornberg M, Kenney LL, Chen AT, Waggoner SN, Kim S-K, Dienes HP, Welsh RM, Selin LK. 2013. Clonal exhaustion as a mechanism to protect against severe immunopathology and death from an overwhelming CD8 T cell response. Front Immunol 4:475. http://dx.doi.org/10.3389 /fimmu.2013.00475.
34. + T cells. Virology 425:122-132. http://dx.doi.org/10.1016 /j.virol.2012.01.005.
35. Waggoner SN, Cornberg M, Selin LK, Welsh RM. 2012. Natural killer cells act as rheostats modulating antiviral T cells. Nature 481:394-398. http://dx.doi.org/10.1038/nature10624.
36. Sheehan M, Haythorn P. 1979. Predictive values of various liver function tests with respect to the diagnosis of liver disease. Clin Biochem 12:262-263. http://dx.doi.org/10.1016/S0009-9120(79)80122-8.
37. Smoller BR, Weishar M, Gray MH. 1990. An unusual cutaneous manifestation of Crohn's disease. Arch Pathol Lab Med 114:609-610.
38. Maggiore G, Grifeo S, Marzani MD. 1983. Erythema nodosum and hepatitis B virus (HBV) infection. J Am Acad Dermatol 9:602-603. http: //dx.doi.org/10.1016/S0190-9622(83)80256-4.
39. Cerwenka A, Morgan TM, Harmsen AG, Dutton RW. 1999. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predictprotection against pulmonary virus infection. J Exp Med 189:423-434. http://dx.doi.org/10.1084/jem.189.2.423.
40. Hamada H, Garcia-Hernandez M de LL Reome JB, Misra SK, Strutt TM, McKinstry KK, Cooper AM, Swain SL, Dutton RW. 2009. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol 182:3469 -3481. http://dx.doi.org/10.4049 /jimmunol.0801814.
41. Zinkernagel RM, Welsh RM. 1976. H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D. J Immunol 117:1495-1502.
42. + T cells is dictated by antigen exposure history and nature of the infection. Immunity 34:781-793. http://dx.doi.org/10.1016/j.immuni.2011.03.020.
43. + TRM cells providing global skin immunity. Nature 483:227-231. http://dx.doi.org/10.1038 /nature10851.
44. + T cells after infection. Nat Immunol 3:619-626. http://dx.doi.org /10.1038/nrm880.
45. + T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells. Nat Immunol 2:415-422.
46. + T cell response. J Exp Med 203:2135-2143. http://dx.doi.org/10.1084/jem .20060928.
47. + bacteria-specific effectormemory T cell populations. Eur J Immunol 33:2875-2885. http://dx.doi .org/10.1002/eji.200324224.
48. + T cells in response to infection is markedly efficient. Science 325:1265-1269. http://dx.doi.org/10.1126 /science.1175455.
49. Wlodarczyk MF, Kraft AR, Chen HD, Kenney LL, Selin LK. 2013. Anti-IFN-γ and peptide-tolerization therapies inhibit acute lung injury induced by cross-reactive influenza A-specific memory T cells. J Immunol 190:2736-2746. http://dx.doi.org/10.4049/jimmunol.1201936.
50. Selin LK, Wlodarczyk MF, Kraft AR, Nie S, Kenney LL, Puzone R, Celada F. 2011. Heterologous immunity: immunopathology, autoimmunity and protection during viral infections. Autoimmunity 44:328-347. http://dx.doi.org/10.3109/08916934.2011.523277.
51. Kedl RM, Rees WA, Hildeman DA, Schaefer B, Mitchell T, Kappler J, Marrack P. 2000. T cells compete for access to antigen-bearing antigenpresenting cells. J Exp Med 192:1105-1113. http://dx.doi.org/10.1084/jem .192.8.1105.
52. + T cells contribute to lymphoproliferation in Epstein-Barr virusassociated infectious mononucleosis. J Clin Invest 115:3602-3612. http: //dx.doi.org/10.1172/JCI25078.
53. Urbani S, Amadei B, Fisicaro P, Pilli M, Missale G, Bertoletti A, Ferrari C. 2005. Heterologous T cell immunity in severe hepatitis C virus infection. J Exp Med 201:675-680. http://dx.doi.org/10.1084/jem.20041058.
54. Welsh RM, Rothman AL. 2003. Dengue immune response: low affinity, high febrility. Nat Med 9:820-822. http://dx.doi.org/10.1038/nm0703 -820.
55. Antunes DA, Rigo MM, Silva JP, Cibulski SP, Sinigaglia M, Chies JAB, Vieira GF. 2011. Structural in silico analysis of cross-genotype-reactivity among naturally occurring HCV NS3-1073-variants in the context of HLA-A * 02:01 allele. Mol Immunol 48:1461-1467. http://dx.doi.org/10 .1016/j.molimm.2011.03.019.
56. Sinigaglia M, Antunes DA, Rigo MM, Chies JAB, Vieira GF. 2013. CrossTope: a curate repository of 3D structures of immunogenic peptide: MHC complexes. Database (Oxford) 2013:bat002. http://dx.doi.org/10 .1093/database/bat002.
57. + memory-phenotype T cells are abundant in unexposed adults. Immunity 38:373-383. http://dx.doi.org/10.1016/j.immuni.2012.10.021.
58. + T cell cross-reactivity profiles and HIV-1 immune escape towards an HLA-B35-restricted immunodominant Nef epitope. PLoS One 8:e66152. http://dx.doi.org/10.1371/journal .pone.0066152.
59. Sewell AK. 2012. Why must T cells be cross-reactive? Nat Rev Immunol 12:669-677. http://dx.doi.org/10.1038/nri3279.
60. + memory T cells by viral variants. J Exp Med 190:1319-1328. http://dx.doi.org/10.1084/jem.190.9.1319.
61. Maeda K, West K, Toyosaki-Maeda T, Rothman AL, Ennis FA, Terajima M. 2004. Identification and analysis for cross-reactivity among hantaviruses of H-2b-restricted cytotoxic T-lymphocyte epitopes in Sin Nombre virus nucleocapsid protein. J Gen Virol 85:1909-1919. http://dx.doi .org/10.1099/vir.0.79945-0.
62. Wedemeyer H, Mizukoshi E, Davis AR, Bennink JR, Rehermann B. Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells. J Virol 75:11392-11400. http://dx .doi.org/10.1128/JVI.75.23.11392-11400.2001.
63. Savage PA, Boniface JJ, Davis MM. 1999. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity 10: 485-492. http://dx.doi.org/10.1016/S1074-7613(00)80048-5.
64. Chen HD, Fraire AE, Joris I, Welsh RM, Selin LK. 2003. Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. Am J Pathol 163:1341-1355. http://dx.doi .org/10.1016/S0002-9440(10)63493-1.
65. + T-cell cross-reactivity and heterologous immunity. Immunol Rev 211:164-181. http://dx.doi .org/10.1111/j.0105-2896.2006.00394.x.
66. Kim S-K, Brehm MA, Welsh RM, Selin LK. 2002. Dynamics of memory T cell proliferation under conditions of heterologous immunity and bystander stimulation. J Immunol 169:90-98. http://dx.doi.org/10.4049 /jimmunol.169.1.90.
67. Kraft ARM, Wlodarczyk MF, Kenney LL, Selin LK. 2013. PC61 (anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection. J Virol 87:12636-12647. http://dx.doi .org/10.1128/JVI.00936-13.
68. Cornberg M, Sheridan BS, Saccoccio FM, Brehm MA, Selin LK. 2007. Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry. J Virol 81:934-944. http://dx.doi.org/10 .1128/JVI.01280-06.
69. Scott LJ, Carter NJ, Curran MP. 2012. Live attenuated influenza vaccine (Fluenz™): a guide to its use in the prevention of seasonal influenza in children in the EU. Paediatr Drugs 14:271-279. http://dx.doi.org/10.2165 /11207080-000000000-00000.
70. Plotkin SA. 2008. Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis 47:401-409. http://dx.doi.org/10.1086/589862.